{"altmetric_id":2828421,"counts":{"readers":{"mendeley":10,"citeulike":0,"connotea":0},"news":{"unique_users_count":2,"unique_users":["medical_news_today","device_space"],"posts_count":2},"total":{"posts_count":9},"twitter":{"unique_users_count":7,"unique_users":["medtech_ma","Datamonitor_AS","rafadiazmd","HeoroCom","CrystalliseL","MrStswe","Oliwer87"],"posts_count":7}},"selected_quotes":["#Model: screening 1000 pts for #AFib after #stroke could prevent 11 strokes, gain 23 QALYs, save EUR 55400: Sweden","Study in #Europace finds that Zenicor's thumb #ECG is effective and saves costs","Zenicor-EKG kursdubbling ? vid screening","Screening of silent #AF by intermittent ECG recordings is cost-effective"],"citation":{"abstract":"The purpose of this study was to estimate the cost-effectiveness of two screening methods for detection of silent AF, intermittent electrocardiogram (ECG) recordings using a handheld recording device, at regular time intervals for 30 days, and short-term 24 h continuous Holter ECG, in comparison with a no-screening alternative in 75-year-old patients with a recent ischaemic stroke.","abstract_source":"pubmed","altmetric_jid":"4f6fa6173cf058f610007321","authors":["Lars-\u00c5ke Levin","Magnus Husberg","Piotr Doliwa Sobocinski","Viveka Frykman Kull","Leif Friberg","M\u00e5rten Rosenqvist","Thomas Davidson"],"doi":"10.1093\/europace\/euu213","endpage":"214","first_seen_on":"2014-10-30T22:09:58+00:00","funders":["niehs"],"issns":["1532-2092","1099-5129"],"issue":"2","journal":"Europace","last_mentioned_on":1474350235,"links":["http:\/\/europace.oxfordjournals.org\/content\/early\/2014\/10\/27\/europace.euu213","http:\/\/dx.doi.org\/10.1093\/europace\/euu213","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25349228","http:\/\/europace.oxfordjournals.org\/content\/17\/2\/207.long","http:\/\/m.europace.oxfordjournals.org\/content\/early\/2014\/10\/27\/europace.euu213"],"pdf_url":"http:\/\/europace.oxfordjournals.org\/content\/europace\/early\/2014\/10\/27\/europace.euu213.full.pdf","pmid":"25349228","pubdate":"2015-02-01T00:00:00+00:00","publisher":"The Oxford University Press","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"207","subjects":["physiology","cardiology"],"title":"A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke","type":"article","volume":"17","mendeley_url":"http:\/\/www.mendeley.com\/research\/costeffectiveness-analysis-screening-silent-atrial-fibrillation-after-ischaemic-stroke-15"},"altmetric_score":{"score":20.95,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":20.95},"context_for_score":{"all":{"total_number_of_other_articles":8409255,"mean":7.0791347310873,"rank":426423,"this_scored_higher_than_pct":94,"this_scored_higher_than":7982390,"rank_type":"exact","sample_size":8409255,"percentile":94},"similar_age_3m":{"total_number_of_other_articles":202382,"mean":8.0425788290405,"rank":13058,"this_scored_higher_than_pct":93,"this_scored_higher_than":189304,"rank_type":"exact","sample_size":202382,"percentile":93},"this_journal":{"total_number_of_other_articles":1188,"mean":3.9100067396799,"rank":35,"this_scored_higher_than_pct":97,"this_scored_higher_than":1153,"rank_type":"exact","sample_size":1188,"percentile":97},"similar_age_this_journal_3m":{"total_number_of_other_articles":58,"mean":0.65175438596491,"rank":1,"this_scored_higher_than_pct":98,"this_scored_higher_than":57,"rank_type":"exact","sample_size":58,"percentile":98}}},"demographics":{"poster_types":{"member_of_the_public":6,"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1,"Members of the public":6}},"mendeley":{"by_status":{"Student  > Doctoral Student":1,"Researcher":1,"Student  > Ph. D. Student":2,"Student  > Postgraduate":1,"Student  > Master":3,"Other":1,"Student  > Bachelor":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":5,"Neuroscience":1,"Psychology":1,"Agricultural and Biological Sciences":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"GB":4,"AR":1,"SE":2}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/medtech_ma\/status\/528133340516200451","license":"datasift","citation_ids":[2828421],"posted_on":"2014-10-31T10:36:15+00:00","author":{"name":"Madeleine","image":"https:\/\/pbs.twimg.com\/profile_images\/786595543426469889\/FRQ9_IFw_normal.jpg","description":"Reporter for EP Vantage. I'm interested in pharma and medtech, as well as anything to do with science, health and general geekery!","id_on_source":"medtech_ma","tweeter_id":"14673628","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":2489},"tweet_id":"528133340516200451"},{"url":"https:\/\/twitter.com\/Datamonitor_AS\/status\/528135289277923328","license":"datasift","rt":["medtech_ma"],"citation_ids":[2828421],"posted_on":"2014-10-31T10:43:59+00:00","author":{"name":"\u00c1ine Kyle","url":"http:\/\/www.datamonitorhealthcare.com","image":"https:\/\/pbs.twimg.com\/profile_images\/781076229717893120\/rJf8tmzy_normal.jpg","description":"Analyst at @Datamonitor_HC covering the pharmaceutical and healthcare industry. Views expressed are my own.","id_on_source":"Datamonitor_AS","tweeter_id":"1394254375","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":415},"tweet_id":"528135289277923328"},{"url":"https:\/\/twitter.com\/rafadiazmd\/status\/587022118778343424","license":"datasift","citation_ids":[2828421],"posted_on":"2015-04-11T22:39:14+00:00","author":{"name":"Rafael D\u00edaz","url":"http:\/\/rafadiazmd.org\/","image":"http:\/\/pbs.twimg.com\/profile_images\/507141579836907520\/iZYJKFgb_normal.png","description":"Padre de dos hermosas hijas. Cardi\u00f3logo. Investigador cl\u00ednico. Interesado por un mont\u00f3n de cosas que alegran mi vida.","id_on_source":"rafadiazmd","tweeter_id":"513506983","geo":{"lt":"-32.9595004","ln":"-60.6615415","country":"AR"},"followers":559},"tweet_id":"587022118778343424"},{"url":"http:\/\/twitter.com\/HeoroCom\/statuses\/659292412938973184","license":"gnip","citation_ids":[2828421],"posted_on":"2015-10-28T08:55:34+00:00","author":{"name":"HEORO","url":"http:\/\/www.heoro.com","image":"https:\/\/pbs.twimg.com\/profile_images\/639720887562969088\/M-kyaktz_normal.png","description":"An effortless and comprehensive approach to burden of illness reviews with our constantly updated and indexed database of studies relevant to HEOR","id_on_source":"HeoroCom","tweeter_id":"3542989396","geo":{"lt":52.16045,"ln":-0.70312,"country":"GB"},"followers":296},"tweet_id":"659292412938973184"},{"url":"http:\/\/twitter.com\/CrystalliseL\/statuses\/659292516198518784","license":"gnip","rt":["HeoroCom"],"citation_ids":[2828421],"posted_on":"2015-10-28T08:55:59+00:00","author":{"name":"Crystallise Limited","url":"http:\/\/www.crystallise.com","image":"https:\/\/pbs.twimg.com\/profile_images\/2617424815\/q3c4u8vbvzgvwsi8261z_normal.png","description":"Crystallise Limited specialises in healthcare analytics, decision support and predictive modelling, and tracking the evidence on health and mortality trends.","id_on_source":"CrystalliseL","tweeter_id":"827622146","geo":{"lt":51.7311,"ln":0.67463,"country":"GB"},"followers":286},"tweet_id":"659292516198518784"},{"url":"http:\/\/twitter.com\/MrStswe\/statuses\/778094899338018816","license":"gnip","citation_ids":[2828421],"posted_on":"2016-09-20T04:54:14+00:00","author":{"name":"MrSt","image":"https:\/\/pbs.twimg.com\/profile_images\/797742400898760704\/4Gb53mYJ_normal.jpg","id_on_source":"MrStswe","tweeter_id":"1323118218","geo":{"lt":62,"ln":15,"country":"SE"},"followers":206},"tweet_id":"778094899338018816"},{"url":"http:\/\/twitter.com\/Oliwer87\/statuses\/778107402025574401","license":"gnip","rt":["MrStswe"],"citation_ids":[2828421],"posted_on":"2016-09-20T05:43:55+00:00","author":{"name":"0lwrr","image":"https:\/\/pbs.twimg.com\/profile_images\/766784814364123136\/2PgvqvRH_normal.jpg","description":"Aktien\u00f6rd\/ekonom\/bils\u00e4ljare. F\u00f6rsmak f\u00f6r diagnostikbolag. \u00d6ver 100% avkastning per \u00e5r hitills","id_on_source":"Oliwer87","tweeter_id":"766779331955847168","geo":{"lt":62,"ln":15,"country":"SE"},"followers":48},"tweet_id":"778107402025574401"}],"news":[{"title":"Swedish study shows Thumb-ECG self monitoring by stroke patients cuts risks of silent atrial fibrillation","url":"http:\/\/www.medicalnewstoday.com\/releases\/284760.php","license":"public","citation_ids":[2828421],"posted_on":"2014-11-03T10:00:00+00:00","summary":"A new clinical study published in Europace, shows that regular screening using a handheld-ECG device on 75-year-old stroke patients for detecting silent atrial fibrillation (AF) is both effective...","author":{"name":"Medical News Today","url":"http:\/\/www.medicalnewstoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/040\/normal\/medical_news_today.png?1369846932"}},{"title":"New Study Shows That Screening With Thumb-ECG Of Stroke Patients Is Both Effective And Provides Longterm Cost Savings","url":"http:\/\/www.devicespace.com\/news_story.aspx?StoryID=352373&full=1","license":"public","citation_ids":[2828421],"posted_on":"2014-10-30T00:00:00+00:00","summary":"A new clinical study published in Europace1, shows that regular screening using a handheld-ECG device on 75-year-old stroke patients for detecting silent atrial fibrillation (AF) is both effective and provides longterm cost savings. The device used was the","author":{"name":"Device Space","url":"http:\/\/www.devicespace.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/840\/normal\/Screen_Shot_2016-02-02_at_15.36.30.png?1454427403"}}]}}